Predicting the Durability of Biological Therapy in Pediatric Crohn's Disease: Do the Immunomodulators Matter?
Clin Gastroenterol Hepatol
.
2015 Oct;13(10):1757-9.
doi: 10.1016/j.cgh.2015.06.007.
Epub 2015 Jun 16.
Authors
Marina Aloi
1
,
Salvatore Cucchiara
1
Affiliation
1
Department of Pediatrics and Childhood Neuropsychiatry, Sapienza University of Rome, Italy; Pediatric Gastroenterology, Hepatology and Digestive Endoscopy Unit, University Hospital Umberto I, Rome, Italy.
PMID:
26091738
DOI:
10.1016/j.cgh.2015.06.007
No abstract available
Publication types
Editorial
Comment
MeSH terms
Crohn Disease / drug therapy*
Female
Humans
Immunologic Factors / administration & dosage*
Infliximab / administration & dosage*
Male
Substances
Immunologic Factors
Infliximab